William Blair Reaffirms Outperform Rating for Simulations Plus (NASDAQ:SLP)

William Blair reaffirmed their outperform rating on shares of Simulations Plus (NASDAQ:SLP) in a report released on Thursday, Benzinga reports. William Blair also issued estimates for Simulations Plus’ Q4 2024 earnings at $0.06 EPS, FY2024 earnings at $0.54 EPS, Q2 2025 earnings at $0.19 EPS, Q4 2025 earnings at $0.19 EPS and FY2025 earnings at $0.67 EPS.

Several other equities analysts also recently commented on the company. Oppenheimer increased their price target on Simulations Plus from $55.00 to $65.00 and gave the company an outperform rating in a report on Thursday, June 13th. KeyCorp started coverage on shares of Simulations Plus in a research report on Monday, July 29th. They set an overweight rating and a $47.00 target price for the company. Craig Hallum reiterated a buy rating and issued a $56.00 price objective on shares of Simulations Plus in a research note on Wednesday, July 3rd. Finally, JMP Securities began coverage on Simulations Plus in a research note on Tuesday, July 16th. They set a market perform rating for the company. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, Simulations Plus presently has a consensus rating of Moderate Buy and an average target price of $56.00.

Simulations Plus Stock Up 0.8 %

SLP stock opened at $32.50 on Thursday. The company has a market capitalization of $650.33 million, a price-to-earnings ratio of 67.71 and a beta of 0.70. The firm has a 50 day moving average of $37.67 and a two-hundred day moving average of $42.96. Simulations Plus has a 12 month low of $32.22 and a 12 month high of $51.22.

Simulations Plus (NASDAQ:SLP) last posted its earnings results on Tuesday, July 2nd. The technology company reported $0.19 EPS for the quarter, topping the consensus estimate of $0.15 by $0.04. The firm had revenue of $18.54 million for the quarter, compared to the consensus estimate of $17.92 million. Simulations Plus had a net margin of 14.36% and a return on equity of 7.80%. The business’s quarterly revenue was up 14.2% on a year-over-year basis. During the same period in the prior year, the business posted $0.20 earnings per share. On average, research analysts expect that Simulations Plus will post 0.51 EPS for the current fiscal year.

Simulations Plus Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, August 5th. Investors of record on Monday, July 29th were given a dividend of $0.06 per share. This represents a $0.24 dividend on an annualized basis and a yield of 0.74%. The ex-dividend date of this dividend was Monday, July 29th. Simulations Plus’s dividend payout ratio (DPR) is presently 50.00%.

Insider Activity at Simulations Plus

In related news, Director Daniel L. Weiner sold 750 shares of the company’s stock in a transaction on Friday, June 28th. The stock was sold at an average price of $49.32, for a total value of $36,990.00. Following the completion of the transaction, the director now directly owns 7,009 shares in the company, valued at $345,683.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the firm’s stock in a transaction dated Monday, July 1st. The shares were sold at an average price of $46.71, for a total transaction of $934,200.00. Following the completion of the transaction, the director now owns 3,540,857 shares in the company, valued at $165,393,430.47. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Daniel L. Weiner sold 750 shares of the company’s stock in a transaction that occurred on Friday, June 28th. The shares were sold at an average price of $49.32, for a total value of $36,990.00. Following the completion of the sale, the director now owns 7,009 shares in the company, valued at $345,683.88. The disclosure for this sale can be found here. Insiders have sold 60,750 shares of company stock worth $2,467,390 over the last three months. Company insiders own 20.90% of the company’s stock.

Institutional Trading of Simulations Plus

A number of large investors have recently bought and sold shares of the stock. Ophir Asset Management Pty Ltd bought a new stake in Simulations Plus during the fourth quarter worth about $7,156,000. Silvercrest Asset Management Group LLC bought a new position in shares of Simulations Plus in the first quarter valued at approximately $4,717,000. Wasatch Advisors LP raised its stake in shares of Simulations Plus by 36.5% in the first quarter. Wasatch Advisors LP now owns 381,693 shares of the technology company’s stock valued at $15,707,000 after acquiring an additional 102,135 shares during the last quarter. Congress Asset Management Co. MA raised its stake in shares of Simulations Plus by 34.6% in the first quarter. Congress Asset Management Co. MA now owns 171,490 shares of the technology company’s stock valued at $7,057,000 after acquiring an additional 44,129 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its stake in shares of Simulations Plus by 10.1% in the second quarter. Dimensional Fund Advisors LP now owns 414,005 shares of the technology company’s stock valued at $20,128,000 after acquiring an additional 37,992 shares during the last quarter. 78.08% of the stock is currently owned by institutional investors.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.